Tag: hMPV


AstraZeneca Acquires Icosavax for $1.1B to Advance RSV and hMPV Vaccine Development

December 13, 2023

Via: HitConsultant

Icosavax’s lead program, IVX-A12, is a Phase III-ready vaccine candidate targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). These viruses are leading causes of severe respiratory infections and hospitalizations in older adults and individuals with chronic conditions. Icosavax’s […]